A Pan-Cancer Clinical Platform to Predict Immunotherapy Outcomes and Prioritize Immuno-Oncology Combinations in Early-Phase Trials

Alberto Hernando, María Vila-Casadesús, Yacine Barèche, Alberto González‐Medina, Francesco M. Mancuso, Deborah Lo Giacco, Ágatha Martín, Omar Saavedra, Irene Braña, María Vieito, Roberta Fasani, John Stagg, Farnoosh Abbas‐Aghababazadeh, Benjamin Haibe‐Kains, Roger Berché, N. Saoudi Gonzalez, Claudia Valverde, Eva Muñoz‐Couselo, Cristina Suárez, Marc Díez, María Elena Elez, Jaume Capdevila, Ana Oaknin, Cristina Saura, Teresa Macarulla, Joan Carles, Enriqueta Felip, Rodrigo Dienstmann, Philippe L. Bédard, Paolo Nucíforo, Joan Seoane, Josep Tabernero, Elena Garralda, Ana VivancosSSRN 2023 · DOI

BibTeX
@misc{hernando2023pan,
  author = {Alberto Hernando and María Vila-Casadesús and Yacine Barèche and Alberto González‐Medina and Francesco M. Mancuso and Deborah Lo Giacco and Ágatha Martín and Omar Saavedra and Irene Braña and María Vieito and Roberta Fasani and John Stagg and Farnoosh Abbas‐Aghababazadeh and Benjamin Haibe‐Kains and Roger Berché and N. Saoudi Gonzalez and Claudia Valverde and Eva Muñoz‐Couselo and Cristina Suárez and Marc Díez and María Elena Elez and Jaume Capdevila and Ana Oaknin and Cristina Saura and Teresa Macarulla and Joan Carles and Enriqueta Felip and Rodrigo Dienstmann and Philippe L. Bédard and Paolo Nucíforo and Joan Seoane and Josep Tabernero and Elena Garralda and Ana Vivancos},
  title = {{A Pan-Cancer Clinical Platform to Predict Immunotherapy Outcomes and Prioritize Immuno-Oncology Combinations in Early-Phase Trials}},
  year = {2023},
  doi = {10.2139/ssrn.4336842},
  howpublished = {SSRN},
}

Loading related content...

Figure